...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Treatment Outcome of Radiotherapy for Localized Primary Ocular Adnexal MALT Lymphoma - Prognostic Effect of the AJCC Tumor-Node-Metastasis Clinical Staging System
【24h】

Treatment Outcome of Radiotherapy for Localized Primary Ocular Adnexal MALT Lymphoma - Prognostic Effect of the AJCC Tumor-Node-Metastasis Clinical Staging System

机译:局部原发性眼部肾上腺MALT淋巴瘤放疗的治疗效果-AJCC肿瘤淋巴结转移临床分期系统的预后效果

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: To analyze the treatment outcome of radiotherapy for localized primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (POAML) and evaluate the prognostic effect of the American Joint Committee on Cancer (AJCC) tumor-node-metastasis (TNM) clinical staging system for POAML. Patients and Methods: Seventy-three patients with Ann Arbor stage IE POAML who were treated with radiotherapy alone were analyzed. T-Factor based on the AJCC staging system was T1 in 28, T2 in 33 and T3 in 12 patients. Results: Out of nine patients with relapse, six had distant and three had contralateral ocular adnexal relapse. One patient died of lymphoma progression. The 5-year local control and progression-free survival (PFS) rates were 100% and 81.5%, respectively. T-Factor was not significantly associated with PFS. Conclusion: Radiotherapy achieved excellent local control and survival rates for stage IE POAML. The AJCC TNM clinical staging system was not significantly predictive for PFS of stage IE POAML.
机译:目的:分析局部原发性眼附属物粘膜相关淋巴样组织淋巴瘤(POAML)的放射治疗结果,并评估美国癌症联合委员会(AJCC)肿瘤淋巴结转移(TNM)临床分期对患者的预后效果POAML。患者和方法:分析了仅接受放疗的Ann Arbor分期IE POAML的73例患者。基于AJCC分期系统的T因子在28例患者中为T1,在33例患者中为T2,在12例患者中为T3。结果:9例复发患者中,6例远处复发,3例对侧眼附件复发。一名患者死于淋巴瘤进展。 5年局部控制率和无进展生存率(PFS)分别为100%和81.5%。 T因子与PFS无显着相关性。结论:IE POAML分期放疗取得了出色的局部控制和生存率。 AJCC TNM临床分期系统不能显着预测IE POAML期的PFS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号